Skip to main content
SupplementScience

Benefits of Quercetin

This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer

Evidence-Based Benefits

  • Senolytic activity — quercetin combined with dasatinib is the most studied senolytic cocktail in clinical research; a 2019 pilot trial (Justice et al.) demonstrated clearance of senescent cells in patients with diabetic kidney disease, reducing inflammatory markers
  • Immune modulation — quercetin stabilizes mast cells and reduces histamine release, which may help manage allergic responses; a 2016 review found quercetin inhibited pro-inflammatory cytokines IL-6, IL-8, and TNF-alpha
  • Anti-inflammatory — quercetin inhibits NF-kB and COX-2 pathways, two central drivers of chronic inflammation, with effects demonstrated in both cell culture and human supplementation trials
  • Cardiovascular support — a meta-analysis of 7 RCTs (Serban et al., 2016) found quercetin supplementation significantly reduced systolic blood pressure by 3.04 mmHg in hypertensive individuals
  • Enhanced bioavailability via phytosome — quercetin phytosome (Quercefit) achieves up to 20x greater plasma levels than standard quercetin dihydrate, meaning lower doses produce stronger effects

What the Research Says

Quercetin has a deep evidence base as a dietary flavonoid with pharmacological activity. Its senolytic potential is the most exciting frontier — the quercetin + dasatinib combination pioneered by Mayo Clinic researchers (Kirkland & Tchkonia, 2020) has entered multiple clinical trials for aging-related diseases. Serban et al. (2016) conducted a comprehensive meta-analysis confirming blood pressure-lowering effects. The phytosome delivery system (Quercefit by Indena) has resolved quercetin's historically poor bioavailability, with Riva et al. (2019) demonstrating up to 20-fold improved plasma concentrations compared to standard quercetin. For immune function, Li et al. (2016) reviewed quercetin's mast cell stabilizing and cytokine-modulating effects.

References

  1. (). Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study. EBioMedicine. DOI
  2. (). Effects of quercetin on blood pressure: a systematic review and meta-analysis of randomized controlled trials. Journal of the American Heart Association. DOI
  3. (). Improved oral absorption of quercetin from quercetin Phytosome, a new delivery system based on food grade lecithin. European Journal of Drug Metabolism and Pharmacokinetics. DOI